- Home
- CRNX vs GENI Comparison
CRNX vs GENI Comparison
Compare CRNX & GENI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- GENI
- Stock Information
- Founded
- CRNX 2008
- GENI 2016
- Country
- CRNX United States
- GENI United Kingdom
- Employees
- CRNX N/A
- GENI N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- GENI Services-Misc. Amusement & Recreation
- Sector
- CRNX Health Care
- GENI Consumer Discretionary
- Exchange
- CRNX Nasdaq
- GENI Nasdaq
- Market Cap
- CRNX 2.8B
- GENI 2.4B
- IPO Year
- CRNX 2018
- GENI N/A
- Fundamental
- Price
- CRNX $31.75
- GENI $10.27
- Analyst Decision
- CRNX Strong Buy
- GENI Strong Buy
- Analyst Count
- CRNX 8
- GENI 14
- Target Price
- CRNX $74.86
- GENI $12.25
- AVG Volume (30 Days)
- CRNX 725.8K
- GENI 5.8M
- Earning Date
- CRNX 08-07-2025
- GENI 08-05-2025
- Dividend Yield
- CRNX N/A
- GENI N/A
- EPS Growth
- CRNX N/A
- GENI N/A
- EPS
- CRNX N/A
- GENI N/A
- Revenue
- CRNX $760,000.00
- GENI $535,167,000.00
- Revenue This Year
- CRNX $402.02
- GENI $23.92
- Revenue Next Year
- CRNX $771.03
- GENI $15.76
- P/E Ratio
- CRNX N/A
- GENI N/A
- Revenue Growth
- CRNX N/A
- GENI 22.89
- 52 Week Low
- CRNX $24.10
- GENI $5.43
- 52 Week High
- CRNX $62.53
- GENI $11.40
- Technical
- Relative Strength Index (RSI)
- CRNX 57.94
- GENI 52.52
- Support Level
- CRNX $28.98
- GENI $9.65
- Resistance Level
- CRNX $32.49
- GENI $10.99
- Average True Range (ATR)
- CRNX 1.24
- GENI 0.44
- MACD
- CRNX 0.30
- GENI 0.05
- Stochastic Oscillator
- CRNX 90.54
- GENI 54.97
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.